The deregulation of NUAK1 activity, usuallyinvolving overexpressionof endogenous protein levels, in both cancer and in neurodevelopmentaldisorders and neurodegenerative disease has encouraged the developmentof inhibitors for this kinase.6,16. This evidence concerns the gene NUAK1 and neurodegenerative disease.